Bacopa Munnieri Q Willmar Schwabe India (30ml)

Original price was: ₹115.00.Current price is: ₹107.00.

Out of stock

  Ask a Question
Compare

Product Description

Also known as bacopa, brahmi

Properties

Potency
1X (Q)
Weight
75 (gms)
Dimensions
3 (cm) x 3 (cm) x 9.4 (cm)

Willmar Schwabe Bacopa Monnieri (Brahmi)

Common Name: Brahmi

Causes & Symptoms for Bacopa (Brahmi)

  • It is a useful medicine for improving the brain activity and helps in difficulties with concentration, impaired memory in healthy individuals.
  • It helps to enhance the speed of learning, reduce the complaints of Alzheimers Disease.
  • Homeopathic Brain tonic that helps to increase the concentration and helps in boosting the memory.
  • It helps the children during exams to remember and improves intelligence.
  • It helps as a general tonic to fight anxiety and stress.
  • It is useful in complaints of Backache, hoarseness, Joint pains.
  • Brahmi is useful in convulsions, it also enhances the fertility in women, efficient working of the kidneys.
  • Bacopa is useful in new born children to avoid the low sugar level effects on their body.
  • It helps to increase the T3 and T4 levels in the blood.

Side effects of Bacopa (Brahmi):

If taken above the mentioned dose, it can cause headache.

People who suffer from low heart rate conditions should avoid using Brahmi.

Dosage and rules while taking Bacopa (brahmi)

Take 10 drops in half cup of water three times a day.

We recommend you to take under physicians guidance.

Interactions and Reactions of Bacopa (Brahmi)

It can react with thyroid medicines, so better take it under physicians guidance.

It should be avoided if blood thinners are being taken.

Terms and ConditionsHomeopathic products have several uses and should be taken on the basis of symptom similarity. Results may vary depending upon the conditions.

There are no reviews yet.

Be the first to review “Bacopa Munnieri Q Willmar Schwabe India (30ml)”

No more offers for this product!

General Inquiries

There are no inquiries yet.